NCT06186427View on ClinicalTrials.gov

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 13, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
CancerMalignant NeoplasmTumorsMetastatic Cancer
Interventions
DIAGNOSTIC_TEST

68Ga-DOTA-GPFAPI-04 PET/CT

The same group of patients underwent 68Ga-DOTA-GPFAPI-04 PET/CT and FDG PET/CT examinations respectively

Trial Locations (1)

510080

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
collaborator

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OTHER

lead

Guangdong Provincial People's Hospital

OTHER